A bone or dental implant material in the form of a paste includes a mixture of calcium phosphate powders, that are capable of forming hydroxyapatite, with liquid glycerol and hydroxypropyl methylcellulose and Na2HPO4. The paste will harden upon exposure to water with the time to harden controlled by the choice and ratio of constituents.
|
7. A paste for bone and tooth restoration comprising, in combination:
a water free mixture of liquid glycerol and powdered tetracalcium phosphate prepared from dicalcium phosphate and calcium carbonate.
1. A composition of matter for dental restoration and bone implants and restoration comprising, in combination:
a mixture of liquid glycerol and a powdered calcium phosphate compound selected from the group consisting of tetracalcium phosphate; anhydrous dicalcium phosphate; α-tricalcium phosphate with calcium carbonate; dicalcium phosphate with calcium hydroxide and mixtures thereof, said mixture being free of water and in the form of a paste.
6. The composition of
10. The paste of
|
This is a utility application based upon provisional application Serial No. 60/263,894 filed Jan. 24, 2001 entitled "Premixed Calcium Phosphate Cement Pastes" for which priority is claimed.
This development was supported in part by USPHS Research Grant DE11789 to the American Dental Association Health Foundation from the NIDCR. The United States or an agency thereof may therefor have certain rights to the claimed invention.
A self-hardening calcium phosphate cement, consisting of tetracalcium phosphate (TTCP) and anhydrous dicalcium phosphate has been shown in clinical studies to be efficacious as a bone repair material. The hardening time (HT) of the cement is about 30 minutes when the powder constituents are mixed with water and 5 minutes when mixed with a phosphate solution as the liquid. Hydroxyapatite (HA) is the major product formed as a result of the mixing and hardening. In recent years, additional calcium phosphate cements (CPC) that do not contain TTCP have been developed, e.g. α-tricalcium phosphate (TCP) and CaCO3; dicalcium phosphate (DCPA) and Ca(OH)2). These cements harden in 10 minutes when mixed with a phosphate solution, and they also form HA as the final product.
A cement paste of the type referenced mixed with glycerol was studied for root canal filling, sealing, and injectability and it was reported that the glycerol-calcium phosphate cement (CPC) paste showed better biocompatibility than a number of presently used root canal filling or sealing materials. However, the prior art did not teach a paste material useful as a bone cement that remains stable over a period of time and hardens only when delivered to a desired site.
The present invention comprises compositions and means for formulating premixed glycerol and calcium phosphate cement pastes that are stable in a package, resist washout, and will harden only after being delivered to the defect or implant site. Glycerol was used as the liquid because the CPC hardening reaction to form HA does not occur in a water-free environment. Hydroxypropyl methylcellulose (HMC) and Na2HPO4 were also added to improve the paste cohesiveness and accelerate cement hardening upon delivery to a desired repair site.
TTCP was prepared by heating an equimolar mixture of commercially obtained DCPA and CaCO3 at 1500°C C. for six hours in a furnace and then quenched in air or inert gas to room temperature. Also, TCP was prepared by heating a mixture that contained 2 mol of DCPA and 1 mol of CaCO3 to 1200°C C. for six hours followed by quenching to room temperature. The powders used were ground individually in a planetary ball mill in cyclohexane, ethanol, or dry to obtain the desired median particle size which is about 15 microns and as disclosed in the prior art for making CPC powders.
Nine liquids containing glycerol and various amounts of HMC (in powder form) and Na2HPO4 (in powder form) were then prepared. Their compositions, expressed as mass fractions (%) of HMC and Na2HPO4, are shown in Table 1. The CPC-I, -II and -III were an equimolar mixture of (1) TTCP and DCPA; (2) α-TCP and CaCO3, and (3) DCPA and Ca(OH)2, respectively. CPC pastes were prepared by mixing the prepared CPC powder with the liquid glycerol mixture at powder-to-liquid ratios of 3.5 to 1 to 1.8 to 2.2 and 1.5 to 1.8, respectively. Diametral tensile strength (DTS) samples were prepared by placing the paste into molds (6 mm diameter×3 mm height) with ≈2 MPa of pressure applied. The DTS samples were kept in a mold covered with two fritted glass slides and immersed in a physiologic-like solution (PLS) [1.15 mM Ca, 1.2 mM P, 133 mM NaC1, 50 HEPES, pH=7.4] at 37°C C. Glycerol-PLS exchange occurred through the fritted glass allowing the CPC to harden. Samples were removed at 4 hours, then immersed in PLS for an additional 20 h. A Universal Testing Machine (United Calibration Corp, Garden Grove, Calif., USA) measured DTD values at a loading rate of 10 mm/min. The Gilmore needle method measured HT. Powder X-ray diffraction analysis (XRD) determined the extent of CPC conversion to HA.
All pastes had excellent washout resistance, they remained stable and hardened while immersed in PLS. The HT and the DTS of 24 hour samples are shown in Table 1. The Newman-Kuels multiple comparison test indicated that the Na2HPO4 amount, not the HMC amount, significantly (P<0.05) affected the DTS and HT. Within each group of HMC amount for CPC-I, the lowest phosphate amount substantially increased the DTS while the highest phosphate amount dramatically reduced the HT. For samples CPC-II and -III, the highest phosphate amount significantly increased the DTS and decreased the HT. X-ray diffraction showed only partial conversion of CPC-I to HA and complete conversions of CPC-II and -III to HA in the 24 hour samples.
TABLE 1 | |||||
Na2NPO4 and HMC compositions expressed as mass | |||||
fraction (%) in glycerol, 24 h DTS and HT. | |||||
Liquid | Na2NPO4 | HMC | DTS (MPa) | HT (Min) | |
CPC-I | |||||
L1 | 7.5 | 0.55 | 4.1 (0.4) | 111 (6) | |
L2 | 15 | 0.55 | 2.8 (0.2) | 93 (3) | |
L3 | 30 | 0.55 | 2.1 (0.2) | 62 (2) | |
L4 | 7.5 | 1.1 | 4.2 (0.2) | 97 (8) | |
L5 | 15 | 1.1 | 2.6 (0.1) | 92 (3) | |
L6 | 30 | 1.1 | 2.6 (0.3) | 63 (3) | |
L7 | 7.5 | 2.2 | 3.6 (0.6) | 97 (6) | |
L8 | 15 | 2.2 | 3.2 (0.3) | 93 (3) | |
L9 | 30 | 2.2 | 2.3 (0.3) | 62 (3) | |
CPC-II | |||||
L1 | 7.5 | 0.55 | 2.0 (0.4) | 117 (3) | |
L2 | 15 | 0.55 | 2.5 (0.2) | 107 (3) | |
L3 | 30 | 0.55 | 3.4 (0.4) | 80 (5) | |
CPC-III | |||||
L1 | 7.5 | 0.55 | 0* | >420 | |
L2 | 15 | 0.55 | 1.0 (0.2) | 170 (5) | |
L3 | 30 | 0.55 | 1.5 (0.1) | 125 (5) | |
The premixed CPC pastes would generally have a longer hardening time and lower physical strength, but the results suggest that cement pastes with excellent washout resistance can be prepared by incorporating HMC and Na2HPO4 in glycerol. Phosphate generally decreased HT and DTS for CPC-I, and increased DTS for CPC-II and -III. HMC appeared to decrease HA formation for CPC-I, but had no effect for CPC-II and -III, and did not affect DTS.
In sum, formation of a bone replacement or dental replacement paste results by combining dry powder constituents, characterized by their conversion to HA in the presence of water or phosphate solutions, with glycerol and hydroxypropyl methyl cellulose and/or Na2HPO4. The ratio of combined constituents is broad and the resulting paste can be formulated to control rather precisely, the hardening times. Glycerol compounds, analogs and substitutes as well as cellulose analogs and substitutes are within the scope of the invention.
Chow, Laurence C., Takagi, Shozo
Patent | Priority | Assignee | Title |
10137061, | Nov 16 2004 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Dental fillers and compositions including phosphate salts |
10166104, | Apr 25 2006 | TELEFLEX MEDICAL INCORPORATED; The University of Connecticut | Calcium phosphate polymer composite and method |
10182973, | Nov 10 2010 | STRYKER EUROPEAN HOLDINGS III, LLC | Polymeric bone foam composition and method |
10286102, | May 11 2010 | HOWMEDICA OSTEONICS CORP | Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods |
10973949, | Dec 13 2013 | Agnovos Healthcare, LLC | Multiphasic bone graft substitute material |
11185475, | Nov 10 2010 | STRYKER EUROPEAN HOLDINGS III, LLC | Polymeric bone foam composition and method |
7066999, | Jul 14 1999 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
7083749, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7083750, | Feb 19 2004 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
7097792, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7097793, | Feb 19 2004 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
7115222, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7118695, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7119038, | Feb 19 2004 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
7122138, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7122139, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7122140, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7128856, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7156915, | Jul 13 2000 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
7157027, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7160381, | Jul 13 2000 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
7160382, | Jul 13 2000 | Calcitec, Inc. | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
7163651, | Feb 19 2004 | CALCITEC, INC | Method for making a porous calcium phosphate article |
7169373, | Jul 14 1999 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
7182895, | May 25 2004 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
7182928, | Jul 13 2000 | Calcitec, Inc. | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
7186294, | Jul 13 2000 | Calcitec, Inc. | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
7201797, | Jul 13 2000 | Calcitec, Inc. | Process for affecting the setting and working time of, bioresorbable calcium phosphate cements |
7204876, | Jul 13 2000 | Calcitec, Inc. | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
7214265, | Jul 13 2000 | Calcitec, Inc. | Injectable calcium phosphate cements and the preparation and use thereof |
7258734, | Jul 14 1999 | Calcitec, Inc. | Injectable calcium phosphate cements and the preparation and use thereof |
7258735, | Jul 14 1999 | Calcitec, Inc. | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
7270705, | Jul 14 1999 | CALCITEC, INC | Method of increasing working time of tetracalcium phosphate cement paste |
7279038, | Jul 13 2000 | Calcitec, Inc. | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
7309232, | Oct 10 2003 | IVOCLAR VIVADENT, INC | Methods for treating dental conditions using tissue scaffolds |
7416602, | Apr 08 2005 | HOWMEDICA OSTEONICS CORP | Calcium phosphate cement |
7459018, | Apr 08 2005 | HOWMEDICA OSTEONICS CORP | Injectable calcium phosphate cement |
7588550, | Mar 14 2003 | Columbia University | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
7709029, | Jan 24 2001 | ADA Foundation | Calcium-containing restoration materials |
7727399, | May 22 2006 | The Trustees of Columbia Univeristy in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
7754246, | Sep 09 2005 | Agnovos Healthcare, LLC | Composite bone graft substitute cement and articles produced therefrom |
7850633, | Mar 14 2003 | The Trustees of Columbia University in the City of New York | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
7892346, | Apr 08 2005 | HOWMEDICA OSTEONICS CORP | Injectable calcium phosphate cement |
7892347, | Apr 08 2005 | HOWMEDICA OSTEONICS CORP | Injectable calcium phosphate cement |
7976874, | Jul 13 2000 | VIVEX BIOLOGICS GROUP, INC | Injectable calcium phosphate cements and the preparation and use thereof |
8021318, | Mar 14 2003 | The Trustees of Columbia University in the City of New York | Methods of blood-based therapies having a microfluidic membraneless exchange device |
8025903, | Sep 09 2005 | Agnovos Healthcare, LLC | Composite bone graft substitute cement and articles produced therefrom |
8083706, | Mar 14 2003 | The Trustees of Columbia University in the City of New York | Apparatus and systems for membraneless separation of fluids |
8092684, | May 22 2006 | The Trustees of Columbia University in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
8097153, | May 22 2006 | The Trustees of Columbia in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
8097162, | May 22 2006 | The Trustees of Columbia University in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
8105086, | Jul 16 2007 | Medical and dental biomaterial and method of use for the same | |
8232327, | Nov 12 2008 | HOWMEDICA OSTEONICS CORP | Tetra calcium phosphate based organophosphorus compositions and methods |
8257593, | May 22 2007 | The Trustees of Columbia University in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
8273803, | Nov 12 2009 | Howmedica Osteonics Corp. | Tetra calcium phosphate based organophosphorus compositions and methods |
8282396, | Jan 24 2001 | ADA Foundation | Calcium-containing restoration materials |
8450388, | Nov 16 2004 | 3M Innovative Properties Company | Dental fillers, methods, compositions including a caseinate |
8470180, | May 22 2006 | The Trustees of Columbia University in the City of New York | Systems and methods of microfluidic membraneless exchange using filtration of extraction outlet streams |
8481065, | Dec 18 2009 | HOWMEDICA OSTEONICS CORP | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
8491516, | Mar 14 2003 | The Trustees of Columbia University in the City of New York | Systems and methods for membraneless dialysis |
8496606, | Feb 04 2008 | The Trustees of Columbia University in the City of New York | Fluid separation devices, systems and methods |
8557038, | Apr 22 2009 | American Dental Association Foundation | Dual-phase calcium phosphate cement composition |
8574611, | Jul 12 2007 | Straumann Holding AG; CAM IMPLANTS B V | Composite bone repair material |
8580865, | Sep 06 2006 | curasan AG | Phase-and sedimentation-stable, plastically deformable preparation with intrinsic pore forming, intended for example for filling bone defects or for use as bone substitute material, and method of producing it |
8685464, | Sep 09 2005 | Agnovos Healthcare, LLC | Composite bone graft substitute cement and articles produced therefrom |
8685465, | Sep 09 2005 | Agnovos Healthcare, LLC | Composite bone graft substitute cement and articles produced therefrom |
8710114, | Nov 16 2004 | 3M Innovative Properties Company | Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof |
8722073, | Dec 18 2009 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
8741268, | Sep 10 2009 | Preventive Technologies, Inc. | Dental prophylactic paste |
8765189, | May 13 2011 | HOWMEDICA OSTEONICS CORP | Organophosphorous and multivalent metal compound compositions and methods |
8790707, | Dec 11 2008 | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | Surface-treated calcium phosphate particles suitable for oral care and dental compositions |
8957126, | Nov 07 2005 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
9101436, | Oct 21 2005 | ADA Foundation | Dental and endodontic filling materials and methods |
9144631, | Jan 27 2003 | ASIUS, BENEDICTE; ASIUS, JEROME; RIVIERE, NICOLAS; BORD, JEAN-MICHEL | Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof |
9168114, | Oct 17 2013 | B & D Dental Corp. | Method of making a dental prosthesis |
9180224, | Sep 09 2005 | Agnovos Healthcare, LLC | Composite bone graft substitute cement and articles produced therefrom |
9233054, | Nov 16 2004 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
9259439, | Oct 21 2005 | ADA Foundation | Dual-phase cement precursor systems for bone repair |
9265857, | May 11 2010 | HOWMEDICA OSTEONICS CORP | Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods |
9414995, | Nov 16 2004 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
9446170, | Dec 13 2013 | Agnovos Healthcare, LLC | Multiphasic bone graft substitute material |
9517186, | Nov 16 2004 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
9642939, | Aug 24 2006 | Graftys; Universite de Nantes | Macroporous and highly resorbable apatitic calcium-phosphate cement |
9668825, | Oct 21 2005 | ADA Foundation | Dental and endodontic filling materials and methods |
Patent | Priority | Assignee | Title |
3679360, | |||
3787900, | |||
3913229, | |||
3929971, | |||
4097935, | Aug 02 1974 | SANOFI S A | Hydroxylapatite ceramic |
4486403, | Jan 01 1982 | Composition for and treatment of teeth | |
4497075, | Oct 08 1979 | Mitsubishi Mining & Cement Co., Ltd. | Filler for filling in defects or hollow portions of bones |
4512038, | Apr 27 1979 | University of Medicine and Dentistry of New Jersey | Bio-absorbable composite tissue scaffold |
4518430, | Apr 29 1982 | American Dental Association Health Foundation; AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION, A CORP ILLINOIS | Dental resptorative cement pastes |
4599085, | Jul 11 1979 | Neodontics, Inc. | Bone implant member for prostheses and bone connecting elements and process for the production thereof |
4612053, | Apr 29 1982 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
4655777, | Dec 19 1983 | Southern Research Institute | Method of producing biodegradable prosthesis and products therefrom |
4880610, | Apr 20 1988 | Norian Corporation | In situ calcium phosphate minerals--method and composition |
4897250, | Oct 31 1986 | Asahi Kogaku Kabushiki Kaisha | Process for producing calcium phosphate |
4963151, | Dec 28 1988 | Trustees of the University of Pennsylvania | Reinforced bone cement, method of production thereof and reinforcing fiber bundles therefor |
5034059, | Feb 17 1989 | Norian Corporation | Composition comprising octacalcium phosphate crystals and polypeptide |
5037639, | May 24 1989 | ADA Foundation | Methods and compositions for mineralizing calcified tissues |
5047031, | Apr 20 1988 | NORIAN CORPORATION, 1025 TERRA BELLA AVE , MOUNTAIN VIEW, CA 94043, A CORP OF CA | In situ calcium phosphate minerals method |
5053212, | Apr 20 1988 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
5092888, | May 19 1989 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
5129905, | Apr 20 1988 | Norian Corporation | Methods for in situ prepared calcium phosphate minerals |
5181930, | Apr 10 1991 | HOWMEDICA OSTEONICS CORP | Composite orthopedic implant |
5192330, | Jan 20 1987 | SMITH & NEPHEW RICHARDS, INC | Orthopedic device of biocompatible polymer with oriented fiber reinforcement |
5236456, | Nov 09 1989 | Warsaw Orthopedic, Inc | Osteogenic composition and implant containing same |
5238491, | Jul 23 1988 | Nitta Gelatin Inc. | Hardening material for medical and dental use |
5336264, | Apr 28 1988 | Norian Corporation | Situ prepared calcium phosphate composition and method |
5455231, | Oct 17 1990 | Norian Corporation | Mineralized collagen |
5496399, | Aug 23 1994 | Norian Corporation | Storage stable calcium phosphate cements |
5522893, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
5525148, | Sep 24 1993 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
5542973, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
5545254, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
5556687, | Oct 14 1994 | DEPUY ACROMED, INC | Composite structure suitable for use as a bone plate and method for making said structure |
5652056, | Aug 20 1996 | Hydroxyapatite filament | |
5695729, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
5721049, | May 08 1995 | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | Composite materials using bone bioactive glass and ceramic fibers |
5766618, | Apr 01 1994 | Massachusetts Institute of Technology | Polymeric-hydroxyapatite bone composite |
5782971, | Oct 16 1992 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
5962028, | Apr 20 1988 | Norian Corporation | Carbonated hydroxyapatite compositions and uses |
5976234, | Sep 24 1993 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
5997624, | Jun 04 1996 | ADA Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
6077989, | May 28 1996 | 1208211 ONTARIO LIMITED | Resorbable implant biomaterial made of condensed calcium phosphate particles |
6136029, | Oct 01 1997 | Phillips Plastics Corporation | Bone substitute materials |
6207098, | Dec 26 1996 | Merck Patent GmbH | Method for producing porous inorganic materials |
6214008, | Apr 16 1997 | White Spot AG | Biodegradable osteosynthesis implant |
6281256, | Mar 31 1997 | The Regents of the University of Michigan | Open pore biodegradable matrices |
6281257, | Apr 27 1998 | MICHIGAN, UNIVERSITY OF THE REGENTS, THE | Porous composite materials |
6287341, | May 19 1995 | Etex Corporation | Orthopedic and dental ceramic implants |
6325992, | Mar 12 1993 | ADA Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
DE4016135, | |||
EP41676, | |||
EP520690, | |||
RE33161, | Apr 29 1982 | Stryker Technologies Corporation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
RE33221, | Apr 29 1982 | Stryker Technologies Corporation | Dental restorative cement pastes |
WO9503369, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 23 2002 | ADA Foundation | (assignment on the face of the patent) | / | |||
Feb 06 2002 | CHOW, LAURENCE C | American Dental Association Health Foundation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 014393 | /0305 | |
Feb 06 2002 | TAKAGI, SHOZO | American Dental Association Health Foundation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 014393 | /0305 | |
Dec 31 2002 | AMERICAN DENTAL HEALTH ASSCIATION FOUNDATION | ADA Foundation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 015443 | /0254 |
Date | Maintenance Fee Events |
Feb 21 2008 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Oct 26 2011 | STOL: Pat Hldr no Longer Claims Small Ent Stat |
Mar 21 2012 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Mar 21 2016 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Sep 21 2007 | 4 years fee payment window open |
Mar 21 2008 | 6 months grace period start (w surcharge) |
Sep 21 2008 | patent expiry (for year 4) |
Sep 21 2010 | 2 years to revive unintentionally abandoned end. (for year 4) |
Sep 21 2011 | 8 years fee payment window open |
Mar 21 2012 | 6 months grace period start (w surcharge) |
Sep 21 2012 | patent expiry (for year 8) |
Sep 21 2014 | 2 years to revive unintentionally abandoned end. (for year 8) |
Sep 21 2015 | 12 years fee payment window open |
Mar 21 2016 | 6 months grace period start (w surcharge) |
Sep 21 2016 | patent expiry (for year 12) |
Sep 21 2018 | 2 years to revive unintentionally abandoned end. (for year 12) |